Induction and mechanism of apoptosis by hydroxycamptothecin in human Tenon's capsule fibroblasts

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 8, 2012, Pages 4874-4880

  Tang, Wei ^a   Zhang, Yujie ^b   Qian, Chaoxu ^a   Yuan, Zhilan ^a   Du, Jun ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

10 HYDROXYCAMPTOTHECIN; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; MESSENGER RNA; 10-HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CAMPTOTHECIN; CYSTEINE PROTEINASE INHIBITOR; DRUG DERIVATIVE; PEPTIDE CHLOROMETHYL KETONE;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; ENZYME INDUCTION; ENZYME REGULATION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TENON CAPSULE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; FIBROBLAST; METABOLISM; PHYSIOLOGY;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CAMPTOTHECIN; CASPASE 3; CASPASE 8; CASPASE 9; CYSTEINE PROTEINASE INHIBITORS; FIBROBLASTS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TENON CAPSULE;

EID: 84867317878     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8968     Document Type: Article

References (41)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Lim TC, Chattopadhyay S, Acharya UR. A survey and comparative study on the instruments for glaucoma detection. Med Eng Phys. 2011;34:129-139.
3. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
4. Strauss GH, Dunn ET, Dunn RC, Bodiford GB, Christie JL. Subconjunctival high dose plasminogen activator in rabbit filtration surgery. J Ocul Pharmacol. 1991;7:9-19.
5. Heuer DK, Parrish RK II, Gressel MG, Hodapp E, Palmberg PF, Anderson DR. 5-fluorouracil and glaucoma filtering surgery. II. A pilot study. Ophthalmology. 1984;91:384-394.
6. Heuer DK, Parrish RK, Gressel MG, et al. 5-Fluorouracil and glaucoma filtering surgery. III. Intermediate follow-up of a pilot study. Ophthalmology. 1986;93:1537-1546.
7. Van Buskirk EM. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1996;122:751-752.
8. Esme A, Yildirim C, Tatlipinar S, Duzcan E, Yaylali V, Ozden S. Effects of intraoperative sponge mitomycin C and 5-fluorouracil on scar formation following strabismus surgery in rabbits. Strabismus. 2004;12:141-148.
9. Yoon PS, Singh K. Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. Curr Opin Ophthalmol. 2004;15:141-146.
10. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120: 297-300.
11. Stewart L, Ireton GC, Parker LH, Madden KR, Champoux JJ. Biochemical and biophysical analyses of recombinant forms of human topoisomerase I. J Biol Chem. 1996;271:7593-7601.
12. Pommier Y, Pourquier P, Fan Y, Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta. 1998;1400:83-105.
13. Gupta D, Bronstein IB, Holden JA. Expression of DNA topoisomerase I in neoplasms of the kidney: correlation with histological grade, proliferation, and patient survival. Hum Pathol. 2000;31:214-219.
14. Koopman M, Antonini NF, Douma J, et al. Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study. Ann Oncol. 2006;17:1523-1528.
15. Luo ZF, Zhou Y, Liu MY. Effects of hydroxycamptothecin and teniposide on proliferation and apoptosis of gastric cancer cell line BGC-823. Ai Zheng. 2007;26:843-845.
16. Zhang XW, Jiang JF, Xu B. Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells. Acta Pharmacol Sin. 2000;21:364-368.
17. Zhang G, Ding L, Renegar R, et al. Hydroxycamptothecin-loaded Fe3O4 nanoparticles induce human lung cancer cell apoptosis through caspase-8 pathway activation and disrupt tight junctions. Cancer Sci. 2011;102:1216-1222.
18. Ling YH, Perez-Soler R, Tseng MT. Effect of DNA topoisomerase I inhibitor, 10-hydroxycamptothecin on the structure and function of nuclei and nuclear matrix in bladder carcinoma MBT-2 cells. Anticancer Res. 1993;13:1613-1617.
19. Wall ME, Wani MC. Camptothecin and taxol: discovery to clinic-thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 1995;55:753-760.
20. Sun Y, Wang L, Sun S, Liu B, Wu N, Cao X. The effect of 10-hydroxycamptothecine in preventing fibroblast proliferation and epidural scar adhesion after laminectomy in rats. Eur J Pharmacol. 2008;593:44-48.
21. Czuwara-Ladykowska J, Makiela B, Smith EA, Trojanowska M, Rudnicka L. The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis. Arthritis Res. 2001;3: 311-318.
22. Luan X, Diekwishch TG. CP27 affects viability, proliferation, attachment and gene expression in embryonic fibroblasts. Cell Prolif. 2002;35:207-219.
23. Wang S, Lv X, Zhang K, et al. Knockdown of the prion gene expression by RNA interference in bovine fibroblast cells. Mol Biol Rep. 2010;37:3193-3198.
24. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
25. Earnshaw WC. Nuclear changes in apoptosis. Curr Opin Cell Biol. 1995;7:337-343.
26. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem. 1999;274:5053-5060.
27. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD-FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J. 1996;315:21-24.
28. Zhu H, Fearnhead HO, Cohen GM. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells. FEBS Lett. 1995;374:303-308.
29. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell. 1996;87:171.
30. Kumar S, Vaux DL. Apoptosis. A cinderella caspase takes center stage. Science. 2002;297:1290-1291.
31. Wang J, Lenardo MJ. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci. 2000;113:753-757.
32. Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 1997;16:2271-2281.
33. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 1996;384:368-372.
34. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 1996; 85:803-815.
35. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 1996;85:817-827.
36. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci. 1996;93:14486-14491.
37. Medema JP, Scaffidi C, Kischkel FC, et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 1997;16:2794-2804.
38. Fernandes-Alnemri T, Armstrong RC, Krebs J, et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci U S A. 1996;93:7464-7469.
39. Darzynkiewicz Z, Bruno S, Del Bino G, Traganos F. The cell cycle effects of camptothecin. Ann N Y Acad Sci. 1996;803: 93-100.
40. Hu W, Zhang C, Fang Y, Lou C. Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo. Toxicol In Vitro. 2011; 25:513-520.
41. Yang SW, Wang W, Xie XY, Zhu WP, Li FQ. In vitro synergistic cytotoxic effect of triptolide combined with hydroxycamptothecin on pancreatic cancer cells. Am J Chin Med. 2011;39: 121-134.